|
38 Companies |
|
50 Products |
|
50 Products |
|
50 Mechanisms of Action |
|
3 Trials |
|
1814 News |
|
| 12345678910111213...3132» |
- |||| Biomarker, Trial termination: Measurement of Smoking-Induced Neutrophil Activation (clinicaltrials.gov) - Oct 4, 2023
P=N/A, N=16, Terminated, Sponsor: Imperial College London
Completed --> Terminated
- | Phase classification: Practicing Self-Control Lowers the Risk of Smoking Lapse (clinicaltrials.gov) - May 10, 2023
P=N/A, N=120, Completed, Sponsor: University at Albany
Completed --> Terminated Phase classification: P1/2 --> P=N/A
- | Enrollment change, Trial termination: Videogame-based Incentives for Smoking Cessation (clinicaltrials.gov) - Apr 26, 2019
P=N/A, N=24, Terminated, Sponsor: Rowan University
Phase classification: P1/2 --> P=N/A N=100 --> 24 | Active, not recruiting --> Terminated; There were a number of bugs in the game that meant the participants were not getting the intended intervention.
- | Trial completion, Enrollment change: System Based Tracking and Treatment for Emergency Patients Who Smoke: STTEPS (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=444, Completed, Sponsor: The Miriam Hospital
N=100 --> 24 | Active, not recruiting --> Terminated; There were a number of bugs in the game that meant the participants were not getting the intended intervention. Recruiting --> Completed | N=692 --> 444
- | Trial completion, Enrollment change: MBSC: A Mindfulness Based Application for Smoking Cessation (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=5, Completed, Sponsor: University of Virginia
Recruiting --> Completed | N=692 --> 444 Active, not recruiting --> Completed | N=88 --> 5
- | Trial completion, Trial completion date, Trial primary completion date, Surgery: STOP-OP: Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=105, Completed, Sponsor: Rigshospitalet, Denmark
Active, not recruiting --> Completed | N=88 --> 5 Recruiting --> Completed | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018
- | Trial completion: Contingency Management for Smoking in Substance Abusers (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=340, Completed, Sponsor: Brown University
Recruiting --> Completed | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018 Recruiting --> Completed
- | Trial completion: A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers (clinicaltrials.gov) - Jan 17, 2019
P=N/A, N=30, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change, Trial termination: Evaluation of Airway Gene Expression in COPD and Controlled Populations (clinicaltrials.gov) - Dec 31, 2018
P=N/A, N=42, Terminated, Sponsor: University of Nebraska
Active, not recruiting --> Completed N=30 --> 42 | Recruiting --> Terminated; Insufficient enrollment
- | Trial completion, Trial completion date, Trial primary completion date: Smoking Cessation Intervention in Public Housing (clinicaltrials.gov) - Dec 13, 2018
P=N/A, N=420, Completed, Sponsor: Medical University of South Carolina
N=30 --> 42 | Recruiting --> Terminated; Insufficient enrollment Enrolling by invitation --> Completed | Trial completion date: Dec 2013 --> May 2018 | Trial primary completion date: Mar 2013 --> May 2018
- | Trial completion: Web and Mobile Smoking Cessation (clinicaltrials.gov) - Dec 13, 2018
P=N/A, N=1266, Completed, Sponsor: Oregon Research Institute
Enrolling by invitation --> Completed | Trial completion date: Dec 2013 --> May 2018 | Trial primary completion date: Mar 2013 --> May 2018 Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date: Intranasal Insulin for Weight Management During Smoking Cessation (clinicaltrials.gov) - Dec 10, 2018
P2, N=26, Completed, Sponsor: Ajna Hamidovic
Active, not recruiting --> Completed Recruiting --> Completed | N=40 --> 26 | Trial completion date: Oct 2017 --> May 2016
- | acetylcysteine solution / Generic mfg.
Trial completion, Enrollment change: A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana (clinicaltrials.gov) - Nov 21, 2018
P2, N=116, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed | N=40 --> 26 | Trial completion date: Oct 2017 --> May 2016 Recruiting --> Completed | N=72 --> 116
- | Phase classification: TC5Redes: Comparison of Internet Stop Smoking Intervention to Usual Care on Smoking Cessation at 6 Months (clinicaltrials.gov) - Nov 16, 2018
P=N/A, N=146, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=72 --> 116 Phase classification: P4 --> P=N/A
- | Trial completion, Phase classification: TCapp-1: San Francisco Stop Smoking App - Pilot Study (clinicaltrials.gov) - Nov 16, 2018
P=N/A, N=9935, Completed, Sponsor: University of California, San Francisco
Phase classification: P4 --> P=N/A Recruiting --> Completed | Phase classification: P1 --> PN/A
- | Chantix (varenicline) / Pfizer
Trial completion, Trial completion date, Trial primary completion date: Tobacco Intervention in Buprenorphine Treatment (clinicaltrials.gov) - Nov 13, 2018
P3, N=175, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | Phase classification: P1 --> PN/A Active, not recruiting --> Completed | Trial completion date: Apr 2015 --> Dec 2016 | Trial primary completion date: Mar 2015 --> Apr 2016
- | Trial completion, Enrollment change: Trial for Tobacco Cessation With Intensive Advice in Diabetic Patients: the ITADI Project (clinicaltrials.gov) - Oct 10, 2018
P=N/A, N=722, Completed, Sponsor: Jordi Gol i Gurina Foundation
Active, not recruiting --> Completed | Trial completion date: Apr 2015 --> Dec 2016 | Trial primary completion date: Mar 2015 --> Apr 2016 Not yet recruiting --> Completed | N=546 --> 722
- | bupropion sustained-release / Generic mfg.
Trial completion, Phase classification, Enrollment change: Combined Pharmaco/Behavior Therapy in Adolescent Smokers (clinicaltrials.gov) - Oct 3, 2018
P2, N=134, Completed, Sponsor: Medical University of South Carolina
Not yet recruiting --> Completed | N=546 --> 722 Recruiting --> Completed | Phase classification: PN/A --> P2 | N=216 --> 134
- | Enrollment change: Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular Risk (clinicaltrials.gov) - Sep 21, 2018
P=N/A, N=7914, Completed, Sponsor: HealthPartners Institute
Recruiting --> Completed | Phase classification: PN/A --> P2 | N=216 --> 134 N=29950 --> 7914
- | Trial completion: Preventing Fetal Body and Brain Size Reduction in Low-income Smoking Mothers: A Randomized Clinical Trial (clinicaltrials.gov) - Sep 19, 2018
P=N/A, N=450, Completed, Sponsor: Hamisu Salihu
N=29950 --> 7914 Active, not recruiting --> Completed
- | Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
Enrollment change, Combination therapy: Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana (clinicaltrials.gov) - Sep 14, 2018
P2, N=23, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed N=49 --> 23
- | Phase classification: Project 2: Strategies for Reducing Nicotine Content in Cigarettes (clinicaltrials.gov) - Aug 15, 2018
P=N/A, N=1250, Completed, Sponsor: Wake Forest University Health Sciences
N=49 --> 23 Phase classification: P3 --> P=N/A
- | Enrollment change, Trial termination: D-cycloserine (DCS) Pretreatment + CBT + Nicotine Replacement Therapy for Smoking Cessation (DCS) (clinicaltrials.gov) - Aug 1, 2018
P1/2, N=22, Terminated, Sponsor: Mclean Hospital
Phase classification: P3 --> P=N/A N=40 --> 22 | Recruiting --> Terminated; left institution protocol closed
- | Trial completion: Nicotine Metabolism and Low Nicotine Cigarettes (clinicaltrials.gov) - Jul 19, 2018
P=N/A, N=207, Completed, Sponsor: University of Pennsylvania
N=40 --> 22 | Recruiting --> Terminated; left institution protocol closed Active, not recruiting --> Completed
- | Phase classification: Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy (clinicaltrials.gov) - Jul 3, 2018
P=N/A, N=60, Completed, Sponsor: Wayne State University
Active, not recruiting --> Completed Phase classification: P1 --> P=N/A
- | Trial completion, Enrollment change, Trial completion date: Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status (clinicaltrials.gov) - Jul 2, 2018
P=N/A, N=280, Completed, Sponsor: Milton S. Hershey Medical Center
Phase classification: P1 --> P=N/A Active, not recruiting --> Completed | N=400 --> 280 | Trial completion date: Oct 2018 --> Feb 2018
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness (clinicaltrials.gov) - Jun 27, 2018
P=N/A, N=58, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Active, not recruiting --> Completed | N=400 --> 280 | Trial completion date: Oct 2018 --> Feb 2018 Active, not recruiting --> Completed | N=110 --> 58 | Trial completion date: Dec 2015 --> Feb 2018 | Trial primary completion date: Apr 2015 --> Feb 2018
- | Chantix (varenicline) / Pfizer
Trial completion, Phase classification, HEOR: Helping HAND2: Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers (clinicaltrials.gov) - Jun 8, 2018
P=N/A, N=1359, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed | N=110 --> 58 | Trial completion date: Dec 2015 --> Feb 2018 | Trial primary completion date: Apr 2015 --> Feb 2018 Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
- | Chantix (varenicline) / Pfizer
Trial completion, Phase classification, Enrollment change: Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity (clinicaltrials.gov) - Jun 3, 2018
P2, N=140, Completed, Sponsor: Medical University of South Carolina
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Recruiting --> Completed | Phase classification: P4 --> P2 | N=214 --> 140
- | Enrollment change: Pulmonary Disease in a Psychiatric Inpatient Population (clinicaltrials.gov) - Jun 1, 2018
P=N/A, N=46, Completed, Sponsor: Psykiatrien Syd
Recruiting --> Completed | Phase classification: P4 --> P2 | N=214 --> 140 N=80 --> 46
- | Biomarker, Trial completion: Biomarkers and Genetic Factors Related to Emphysema (clinicaltrials.gov) - May 4, 2018
P=N/A, N=145, Completed, Sponsor: Washington University School of Medicine
N=80 --> 46 Active, not recruiting --> Completed
- | Chantix (varenicline) / Pfizer
Trial termination: Alternate Nicotine Delivery Systems and Airway Epithelial Biology (clinicaltrials.gov) - May 3, 2018
P=N/A, N=96, Terminated, Sponsor: Weill Medical College of Cornell University
Active, not recruiting --> Completed Recruiting --> Terminated; Grant Ended
- | Trial completion: A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs) (clinicaltrials.gov) - Apr 27, 2018
P3, N=147, Completed, Sponsor: Montefiore Medical Center
Recruiting --> Terminated; Grant Ended Recruiting --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: A Trial of Positively Smoke Free Group Therapy for HIV-infected Smokers (clinicaltrials.gov) - Apr 27, 2018
P=N/A, N=449, Completed, Sponsor: Montefiore Medical Center
Recruiting --> Completed Not yet recruiting --> Completed | Trial completion date: Aug 2018 --> Mar 2018 | Trial primary completion date: Aug 2017 --> Mar 2018
- | Trial completion, Trial primary completion date: BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit (clinicaltrials.gov) - Apr 24, 2018
P=N/A, N=331, Completed, Sponsor: Duke University
Not yet recruiting --> Completed | Trial completion date: Aug 2018 --> Mar 2018 | Trial primary completion date: Aug 2017 --> Mar 2018 Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Dec 2017
- | Trial completion, Trial primary completion date: Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy (clinicaltrials.gov) - Apr 18, 2018
P1, N=60, Completed, Sponsor: Wayne State University
Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Dec 2017 Active, not recruiting --> Completed | Trial primary completion date: Nov 2017 --> Apr 2017
- | Phase classification, Enrollment change: Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia (clinicaltrials.gov) - Apr 6, 2018
P, N=62, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Active, not recruiting --> Completed | Trial primary completion date: Nov 2017 --> Apr 2017 Phase classification: P=N/A --> P | N=120 --> 62
- | Chantix (varenicline) / Pfizer
Phase classification, Enrollment change: A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control (clinicaltrials.gov) - Apr 6, 2018
P, N=61, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Phase classification: P=N/A --> P | N=120 --> 62 Phase classification: P=N/A --> P | N=100 --> 61
- | Trial completion, Phase classification, Enrollment change: Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis (clinicaltrials.gov) - Apr 6, 2018
P, N=177, Completed, Sponsor: Ohio State University
Phase classification: P=N/A --> P | N=100 --> 61 Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 177
- | Phase classification, Enrollment change: Brain Circuits in Schizophrenia and Smoking (clinicaltrials.gov) - Apr 6, 2018
P, N=42, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 177 Phase classification: P=N/A --> P | N=300 --> 42
- | Phase classification, Enrollment change: Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms (clinicaltrials.gov) - Apr 6, 2018
P, N=822, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Phase classification: P=N/A --> P | N=300 --> 42 Phase classification: P=N/A --> P | N=1230 --> 822
- | Phase classification, HEOR: Medical Marijuana Use in HIV+ Patients Prospective Cohort Study (clinicaltrials.gov) - Apr 6, 2018
P, N=119, Completed, Sponsor: Wayne State University
Phase classification: P=N/A --> P | N=1230 --> 822 Phase classification: P=N/A --> P
- | Phase classification, Enrollment change: Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms (clinicaltrials.gov) - Apr 6, 2018
P, N=92, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Phase classification: P=N/A --> P Phase classification: P=N/A --> P | N=230 --> 92
- | Trial completion: Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (clinicaltrials.gov) - Apr 6, 2018
P2/3, N=278, Completed, Sponsor: Oregon Health and Science University
Phase classification: P=N/A --> P | N=230 --> 92 Active, not recruiting --> Completed
- | galantamine extended release / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Apr 6, 2018
P2, N=98, Completed, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Mar 2018 --> Nov 2017 | Trial primary completion date: Feb 2018 --> Nov 2017
- | Enrollment change: Effects of Smoking on Opioid Receptor Binding: A PET Study (clinicaltrials.gov) - Apr 6, 2018
P1, N=26, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed | Trial completion date: Mar 2018 --> Nov 2017 | Trial primary completion date: Feb 2018 --> Nov 2017 N=40 --> 26
- | Phase classification: Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco Abstinence (clinicaltrials.gov) - Apr 6, 2018
P, N=119, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
N=40 --> 26 Phase classification: P=N/A --> P
- | Phase classification: Effect of Lung Cancer Diagnoses on Family Behaviors (clinicaltrials.gov) - Apr 5, 2018
P, N=507, Completed, Sponsor: National Human Genome Research Institute (NHGRI)
Phase classification: P=N/A --> P Phase classification: P=N/A --> P
- | FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion, Phase classification, Enrollment change: Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (clinicaltrials.gov) - Apr 4, 2018
P, N=62, Completed, Sponsor: University of North Carolina, Chapel Hill
Phase classification: P=N/A --> P Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 62
- | Trial completion: Project 2: Strategies for Reducing Nicotine Content in Cigarettes (clinicaltrials.gov) - Mar 27, 2018
P3, N=1250, Completed, Sponsor: Wake Forest University Health Sciences
Recruiting --> Completed | Phase classification: PN/A --> P | N=100 --> 62 Active, not recruiting --> Completed